Literature DB >> 12815573

Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients.

Brian E Jaski1, Jae Ha, Bart G Denys, Sumant Lamba, Robin J Trupp, William T Abraham.   

Abstract

BACKGROUND: Veno-venous ultrafiltration may benefit patients with acute or chronic circulatory volume overload. Use of conventional systems, however, may be cumbersome, requiring physician placement of a double-lumen central venous catheter and use of a dedicated dialysis technician and apparatus.
METHODS: A simplified peripheral ultrafiltration system including a miniaturized disposable circuit was evaluated in patients with volume-overload states. Separate intravenous catheters (16-18 G) for withdrawal and return of blood (blood flow <or= 40 mL/min, ultrafiltrate <or= 500 mL/h) were placed by nonphysician personnel in upper extremity veins. Twenty-five treatments of up to 8 hours were performed in 21 patients.
RESULTS: The primary endpoint of greater than 1 L fluid removal in less than 8 hours was achieved in 23 of 25 treatments. On average, 2611 +/- 1002 mL (maximum 3,725 mL) of ultrafiltrate was removed per treatment (treatment period 6:43 +/- 1:47 hours:minutes). Patient weight decreased from 91.9 +/- 17.5 to 89.3 +/- 17.3 kg (P <.0001) after ultrafiltration. No major adverse events occurred.
CONCLUSIONS: Rapid removal of extracellular and intravascular fluid volume excess can be safely achieved via peripherally inserted ultrafiltration without the need for central venous catheter placement.

Entities:  

Mesh:

Year:  2003        PMID: 12815573     DOI: 10.1054/jcaf.2003.28

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  28 in total

Review 1.  Emerging therapies for heart failure: renal mechanisms and effects.

Authors:  Amir Kazory; Edward A Ross
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

2.  Ultrafiltration in patients with decompensated heart failure and diuretic resistance: an Asian centre's experience.

Authors:  Loon Yee Louis Teo; Choon Pin Lim; Chia Lee Neo; Lee Wah Teo; Swee Ling Elaine Ng; Laura Lihua Chan; Manish Kaushik; Kheng Leng David Sim
Journal:  Singapore Med J       Date:  2016-01-15       Impact factor: 1.858

Review 3.  Ultrafiltration in decompensated heart failure.

Authors:  Brian E Jaski; David Miller
Journal:  Curr Heart Fail Rep       Date:  2005-09

Review 4.  Quality of care and outcomes in acute decompensated heart failure: The ADHERE Registry.

Authors:  Clyde W Yancy; Gregg C Fonarow
Journal:  Curr Heart Fail Rep       Date:  2004-09

Review 5.  Diuretic resistance in heart failure.

Authors:  Srinivas Iyengar; William T Abraham
Journal:  Curr Heart Fail Rep       Date:  2006-04

6.  The role of ultrafiltration in the management of heart failure.

Authors:  Maria Rosa Costanzo
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-08

Review 7.  Management of acute decompensated heart failure.

Authors:  Larry A Allen; Christopher M O'Connor
Journal:  CMAJ       Date:  2007-03-13       Impact factor: 8.262

8.  Optimal use of diuretics in patients with heart failure.

Authors:  Jigar Patel; Michael Smith; J Thomas Heywood
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-08

Review 9.  Treatment of congestion in heart failure with diuretics and extracorporeal therapies: effects on symptoms, renal function, and prognosis.

Authors:  Maria Rosa Costanzo; Mariell Jessup
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

10.  Aquapheresis (AQ) in Tandem with Extracorporeal Membrane Oxygenation (ECMO) in Pediatric Patients.

Authors:  Alex R Constantinescu; Jason L Adler; Eileen Watkins; Xamayta L Negroni-Balasquide; De'Ann Laufenberg; Frank G Scholl; Gerald J Lavandosky
Journal:  J Extra Corpor Technol       Date:  2019-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.